Large Cap Biopharmaceuticals 2022: Market Performance and Metrics…Update-1 rally time
Update-1 11/22 Broad Market Rally with all major indices up over 1%. Small cap spec stocks gain momentum, XBI up 1.38%. Energy materials and tech strong. IBB up 0.79% to $134. Bears acknowledge year end strength but still say 2023 fraught with weakening economy and uncertainty on earnings...
Healthcare Sectors Update-Time to Review Your Portfolio…Update-1
Update-1 11/18...Healthcare stocks had a good week with the XLV up almost 1% to $134 despite choppiness. We are still facing MACRO headwinds and the FED so stay cautious. There was good tape action in mid-cap biopharmas. Medtech is looking better with the IHI up 4% for the week but the sector...
We are Back Online, Updates Coming 11/15
Raygent is back online. We'll try to get updates to you in coming days. Both the IBB and XBI are up about 5% over the past five days. The XLV is weaker due to weakness in UNH.
Epic Pacific Storms of 2022-24 Season. Update- BOMB CYCLONE NOV 2024
Bomb Cyclone hits Northwest Coast CA and OR Record-setting bomb cyclone, intense as a hurricane, lashes Northwest https://www.washingtonpost.com/weather/2024/11/19/atmospheric-river-bomb-cyclone-california-low-pressure/ A record-strong low-pressure system will steer an atmospheric river into...
Biotech Stocks Ruffled During FedSpeak Week..Update-1
Update-1 Nov. 8..Volatile election day favors the bulls. IBB and XBI both up over 1%. TSY yields down and dollar down. UNH up 1.48%, Junior metals are hot with gold and silver. Crypto spat rattles markets. Amgen (AMGN) leads the way up over 5% to $290 level a record high. New clinical dat...